Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Cancer Immunol Immunother
; 71(4): 979-987, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34467417
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
Limits:
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
Argentina
Country of publication:
Alemania